Aging
Navigate
Submit an Article
Research Paper|Volume 16, Issue 11|pp. 9569–9583
Attenuating bone loss in osteoporosis: the potential of corylin (CL) as a therapeutic agent
Back to articleFigure 8(8 of 8)
100%
Figure 8
Figure 8.Inhibition of osteoclast formation in vivo by CL administration. (A) The TRAP staining image from bone samples. (B, C) The histomorphometric quantifying (N.Oc/BS and OcS/BS) of TRAP-positive osteoclasts. ***P < 0.001; ****P < 0.0001.